TCP10L synergizes with MAD1 in transcriptional suppression and cell cycle arrest through mutual interaction |
Shen, Suqin
(State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University)
Zuo, Jie (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Feng, Huan (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Bai, Meirong (Cardiovascular Research Institute and Department of Physiology, University of California) Wang, Chenji (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Wei, Youheng (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Li, Yanhong (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Le, Yichen (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Wu, Jiaxue (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Wu, Yanhua (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Yu, Long (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) |
1 | Luscher B (2012) MAD1 and its life as a MYC antagonist: an update. Eur J Cell Biol 91, 506-514 DOI |
2 | Sommer A, Bousset K, Kremmer E, Austen M and Luscher B (1998) Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators. J Biol Chem 273, 6632-6642 DOI |
3 | van Riggelen J, Yetil A and Felsher DW (2010) MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 10, 301-309 DOI |
4 | Cultraro CM, Bino T and Segal S (1997) Regulated expression and function of the c-Myc antagonist, Mad1, during a molecular switch from proliferation to differentiation. Curr Top Microbiol Immunol 224, 149-158 |
5 | Cerni C, Skrzypek B, Popov N et al (2002) Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1. Oncogene 21, 447-459 DOI |
6 | Gunes C, Lichtsteiner S, Vasserot AP and Englert C (2000) Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res 60, 2116-2121 |
7 | Werner S, Beer HD, Mauch C and Luscher B (2001) The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis. Oncogene 20, 7494-7504 DOI |
8 | Zhu J, Blenis J and Yuan J (2008) Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proc Natl Acad Sci U S A 105, 6584-6589 DOI |
9 | Chen Z, Yu L, Wu H et al (2003) Identification of a novel liver-specific expressed gene, TCP10L, encoding a human leucine zipper protein with transcription inhibition activity. J Hum Genet 48, 556-563 DOI |
10 | Laherty CD, Yang WM, Sun JM, Davie JR, Seto E and Eisenman RN (1997) Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349-356 DOI |
11 | Zhong Z, Qiu J, Chen X et al (2008) Identification of TCP10L as primate-specific gene derived via segmental duplication and homodimerization of TCP10L through the leucine zipper motif. Mol Biol Rep 35, 171-178 DOI |
12 | Zuo J, Cai H, Wu Y et al TCP10L acts as a tumor suppressor by inhibiting cell proliferation in hepatocellular carcinoma. Biochem Biophys Res Commun 446, 61-67 DOI |
13 | Jiang DJ, Yu HX, Hexige SY et al (2004) Human liver specific transcriptional factor TCP10L binds to MAD4. J Biochem Mol Biol 37, 402-407 DOI |
14 | Wang Y, Toury R, Hauchecorne M and Balmain N (1997) Expression and subcellular localization of the Myc superfamily proteins: c-Myc, Max, Mad1 and Mxi1 in the epiphyseal plate cartilage chondrocytes of growing rats. Cell Mol Biol (Noisy-le-grand) 43, 175-188 |
15 | Rottmann S and Luscher B (2006) The Mad side of the Max network: antagonizing the function of Myc and more. Curr Top Microbiol Immunol 302, 63-122 |
16 | Xu L, Zhu J, Hu X et al (2007) c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1. Mol Cell 28, 914-922 DOI |
17 | Yu H, Jiang D, Guo Z et al (2005) TCP10L is expressed specifically in spermatogenic cells and binds to death associated protein kinase-3. Int J Androl 28, 163-170 DOI |
18 | Brognard J, Zhang YW, Puto LA and Hunter T (2011) Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinase. Cancer Res 71, 3152-3161 DOI |
19 | Kawai T, Matsumoto M, Takeda K, Sanjo H and Akira S (1998) ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol Cell Biol 18, 1642-1651 DOI |
20 | Komatsu S and Ikebe M (2004) ZIP kinase is responsible for the phosphorylation of myosin II and necessary for cell motility in mammalian fibroblasts. J Cell Biol 165, 243-254 DOI |
21 | Hurlin PJ, Queva C, Koskinen PJ et al (1996) Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 15, 2030 |
22 | Xu D, Popov N, Hou M et al (2001) Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci U S A 98, 3826-3831 DOI |